Hangzhou Coco Healthcare Products Co Ltd
SZSE:301009
Income Statement
Earnings Waterfall
Hangzhou Coco Healthcare Products Co Ltd
Revenue
|
1.1B
CNY
|
Cost of Revenue
|
-951.7m
CNY
|
Gross Profit
|
192.2m
CNY
|
Operating Expenses
|
-250m
CNY
|
Operating Income
|
-57.8m
CNY
|
Other Expenses
|
27.1m
CNY
|
Net Income
|
-30.7m
CNY
|
Income Statement
Hangzhou Coco Healthcare Products Co Ltd
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
1 635
N/A
|
1 654
+1%
|
1 466
-11%
|
1 268
-13%
|
1 186
-6%
|
1 175
-1%
|
1 132
-4%
|
1 169
+3%
|
1 186
+1%
|
1 183
0%
|
1 173
-1%
|
1 144
-2%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(1 182)
|
(1 203)
|
(1 124)
|
(979)
|
(973)
|
(1 003)
|
(996)
|
(1 043)
|
(1 043)
|
(1 019)
|
(995)
|
(952)
|
|
Gross Profit |
453
N/A
|
451
0%
|
342
-24%
|
289
-16%
|
213
-26%
|
173
-19%
|
136
-21%
|
125
-8%
|
144
+14%
|
164
+14%
|
178
+8%
|
192
+8%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(145)
|
(183)
|
(142)
|
(151)
|
(180)
|
(190)
|
(205)
|
(194)
|
(178)
|
(243)
|
(242)
|
(250)
|
|
Selling, General & Administrative |
(92)
|
(101)
|
(95)
|
(108)
|
(126)
|
(137)
|
(152)
|
(142)
|
(126)
|
(128)
|
(119)
|
(128)
|
|
Research & Development |
(56)
|
(58)
|
(52)
|
(45)
|
(46)
|
(49)
|
(51)
|
(51)
|
(46)
|
(50)
|
(48)
|
(46)
|
|
Depreciation & Amortization |
(10)
|
(5)
|
(5)
|
0
|
(12)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
|
Other Operating Expenses |
13
|
(19)
|
11
|
3
|
4
|
(3)
|
(3)
|
(1)
|
7
|
(65)
|
(74)
|
(75)
|
|
Operating Income |
308
N/A
|
268
-13%
|
201
-25%
|
139
-31%
|
33
-76%
|
(17)
N/A
|
(69)
-298%
|
(69)
+1%
|
(34)
+50%
|
(78)
-130%
|
(64)
+19%
|
(58)
+9%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(20)
|
(23)
|
(22)
|
(0)
|
12
|
15
|
32
|
43
|
40
|
35
|
35
|
20
|
|
Non-Reccuring Items |
(33)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(62)
|
0
|
0
|
(0)
|
|
Total Other Income |
(1)
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
(1)
|
(1)
|
(2)
|
|
Pre-Tax Income |
254
N/A
|
246
-3%
|
179
-27%
|
137
-23%
|
44
-68%
|
(4)
N/A
|
(39)
-878%
|
(26)
+33%
|
(56)
-116%
|
(45)
+21%
|
(30)
+33%
|
(39)
-31%
|
|
Net Income | |||||||||||||
Tax Provision |
(31)
|
(30)
|
(20)
|
(16)
|
(4)
|
3
|
7
|
6
|
0
|
(2)
|
(4)
|
(4)
|
|
Income from Continuing Operations |
223
|
216
|
159
|
122
|
39
|
(1)
|
(32)
|
(20)
|
(56)
|
(46)
|
(34)
|
(43)
|
|
Income to Minority Interest |
(9)
|
(9)
|
(9)
|
(6)
|
0
|
3
|
5
|
5
|
13
|
12
|
12
|
13
|
|
Net Income (Common) |
214
N/A
|
161
-25%
|
104
-35%
|
69
-33%
|
40
-43%
|
1
-96%
|
(27)
N/A
|
(15)
+45%
|
(43)
-189%
|
(34)
+21%
|
(22)
+36%
|
(31)
-41%
|
|
EPS (Diluted) |
0.79
N/A
|
0.59
-25%
|
0.38
-36%
|
0.25
-34%
|
0.15
-40%
|
0.01
-93%
|
-0.1
N/A
|
-0.05
+50%
|
-0.16
-220%
|
-0.13
+19%
|
-0.08
+38%
|
-0.11
-38%
|